Shimizu K, Toyoda N, Morikawa F, Sugiyama Y
Nihon Naibunpi Gakkai Zasshi. 1983 Dec 20;59(12):1894-904. doi: 10.1507/endocrine1927.59.12_1894.
To investigate the effect of pregnancy on the course of streptozotocin (STZ) induced diabetes, insulin binding to receptors and glucose transport activity were studied in isolated adipocytes from normal nonpregnant, normal pregnant, STZ-treated nonpregnant and STZ-treated pregnant rats. Experimental diabetes was induced by the administration of 40 mg/kg of STZ, and those exhibiting blood sugar concentrations between 150 and 250 mg/100 ml (198.8 +/- 6.4 mg/100 ml, mean +/- SEM) 7 days after treatment, were then used for the experiments as diabetic animals. Rats were mated at least 10 days after STZ administration. All studies were performed on gestational day 19. Fetuses of the diabetic mothers tended to be heavier than those of the control rats (2.49 +/- 0.31 vs. 2.38 +/- 0.22 g, mean +/- SD), but the difference was not statistically significant. Placental weights were significantly greater in the diabetics than in the controls (0.60 +/- 0.12 vs. 0.48 +/- 0.097 g, mean /+- SD, p less than 0.05). Insulin binding to receptors at an insulin concentration of 0.2 ng/ml was increased by 21% in the STZ-treated nonpregnant group as compared with the untreated non-pregnant group, by 32% in the STZ-treated pregnant group as compared with the untreated pregnant group due to increased receptor affinity without increasing the receptor number. However, no change in insulin binding was detected between the normal nonpregnant and normal pregnant, STZ-treated nonpregnant and STZ-treated pregnant groups. Glucose transport activity was decreased in adipocytes from the normal pregnant group as compared with that of the normal nonpregnant group. The effect was also observed between adipocytes from the sTZ-treated pregnant group and from the STZ-treated nonpregnant group. Adipocytes from rats belonging to either the normal pregnant group or the STZ-treated nonpregnant group showed a similar decrease in glucose transport activity, suggesting an equal effect of pregnancy and mild diabetes on glucose transport. Furthermore, adipocytes from the STZ-treated pregnant group showed the lowest transport activity of the four groups studied, suggesting an additive effect of pregnancy and diabetes on glucose transport activity. In conclusion, although insulin action in isolated adipocytes is reduced by pregnancy whether diabetes is induced or not, insulin binding to receptors is not changed by pregnancy. Thus, the effect on insulin action in adipocytes from diabetic rats as well as normal rats might lie at a site distal to the receptor. Insulin action in isolated adipocytes is reduced additively by pregnancy and diabetes.
为研究妊娠对链脲佐菌素(STZ)诱导的糖尿病病程的影响,我们对来自正常未孕、正常妊娠、STZ处理的未孕及STZ处理的妊娠大鼠的分离脂肪细胞中的胰岛素受体结合及葡萄糖转运活性进行了研究。通过给予40mg/kg的STZ诱导实验性糖尿病,处理7天后血糖浓度在150至250mg/100ml之间(198.8±6.4mg/100ml,均值±标准误)的大鼠作为糖尿病动物用于实验。大鼠在给予STZ至少10天后进行交配。所有研究均在妊娠第19天进行。糖尿病母亲的胎儿往往比对照大鼠的胎儿更重(2.49±0.31 vs. 2.38±0.22g,均值±标准差),但差异无统计学意义。糖尿病组的胎盘重量显著高于对照组(0.60±0.12 vs. 0.48±0.097g,均值±标准差,p<0.05)。在胰岛素浓度为0.2ng/ml时,STZ处理的未孕组与未处理的未孕组相比,胰岛素与受体的结合增加了21%;STZ处理的妊娠组与未处理妊娠组相比,由于受体亲和力增加而受体数量未增加,胰岛素与受体的结合增加了32%。然而,正常未孕与正常妊娠、STZ处理的未孕与STZ处理的妊娠组之间未检测到胰岛素结合的变化。与正常未孕组相比,正常妊娠组脂肪细胞中的葡萄糖转运活性降低。在STZ处理的妊娠组与STZ处理的未孕组的脂肪细胞之间也观察到了这种效应。正常妊娠组或STZ处理的未孕组大鼠的脂肪细胞显示出相似的葡萄糖转运活性降低,表明妊娠和轻度糖尿病对葡萄糖转运有相同的影响。此外,STZ处理的妊娠组脂肪细胞在研究的四组中显示出最低的转运活性,表明妊娠和糖尿病对葡萄糖转运活性有累加效应。总之,尽管无论是否诱导糖尿病,妊娠都会降低分离脂肪细胞中的胰岛素作用,但妊娠不会改变胰岛素与受体的结合。因此,对糖尿病大鼠及正常大鼠脂肪细胞中胰岛素作用的影响可能位于受体远端。妊娠和糖尿病对分离脂肪细胞中胰岛素作用的影响具有累加性。